TY  - CHAP
M1  - Book, Section
TI  - Chapter 17. Renal Replacement Therapy
A1  - Nolen, Jacqueline G.
A1  - Cota, Jason M.
A2  - Attridge, Rebecca L.
A2  - Miller, Monica L.
A2  - Moote, Rebecca
A2  - Ryan, Laurajo
Y1  - 2013
N1  - 
T2  - Internal Medicine: A Guide to Clinical Therapeutics
AB  - Kt/V  &  URR:  measures  of  renal  replacement  therapy  (RRT)  adequacyDialysate:  solution  used  to  facilitate  diffusion  during  RRTDialyzer/filter/dialysis  membrane:  semipermeable  membrane  utilized  to  facilitate  solute  &  fluid  removal;  surface  area  &  pore  size  determine  size  of  solutes  removed  &  ultrafiltration  of  fluidFlow  rates:  QB,  blood  flow  rate;  QD,  dialysate  flow  rate;  QUF,  ultrafiltration  flow  rateDry  weight  (kg):  body  weight,  patient  is  volume  neutralVascular  access:  arteriovenous  (AV)  in  chronic  intermittent  hemodialysis  (IHD);  venovenous  (VV)  in  continuous  renal  replacement  therapy  (CRRT);  AV  fistula  or  graft  in  chronic  RRT;  central  venous  catheters  (CVC)  in  emergent  RRT  (especially  CRRT  or  hybrid  IHD;  internal  jugular  [IJ]  preferred,  ↑  infection  rate  with  femoral  &  ↑  risk  of  stenosis  with  subclavian)  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/23
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=57288275
ER  -